178 related articles for article (PubMed ID: 36578034)
1. A personal acquisition time regimen of
Xiao J; Yu H; Sui X; Liu G; Cao Y; Yanzhao Z; Zhang Y; Hu P; Cheng D; Shi H
Cancer Imaging; 2022 Dec; 22(1):78. PubMed ID: 36578034
[TBL] [Abstract][Full Text] [Related]
2. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by
Xiao J; Yu H; Sui X; Hu Y; Cao Y; Liu G; Zhang Y; Hu P; Wang Y; Li C; Xu B; Shi H
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):269-278. PubMed ID: 34185138
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
4. Activity Dose Reduction in
Loft M; Carlsen EA; Johnbeck CB; Jensen CV; Andersen FL; Langer SW; Oturai P; Knigge U; Kjaer A
Mol Imaging Biol; 2022 Aug; 24(4):600-611. PubMed ID: 35167028
[TBL] [Abstract][Full Text] [Related]
5. Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumors.
Wong KK; Frey KA; Niedbala J; Kaza RK; Worden FP; Fitzpatrick KJ; Dewaraja YK
Nucl Med Commun; 2022 Aug; 43(8):892-900. PubMed ID: 35703269
[TBL] [Abstract][Full Text] [Related]
6. Head-to-Head Comparison of
Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
[No Abstract] [Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Parametric Net Influx Rate Images of
Ilan E; Sandström M; Velikyan I; Sundin A; Eriksson B; Lubberink M
J Nucl Med; 2017 May; 58(5):744-749. PubMed ID: 27789716
[No Abstract] [Full Text] [Related]
9. A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice.
Aalbersberg EA; Geluk-Jonker MM; Young-Mylvaganan T; de Wit-van der Veen LJ; Stokkel MPM
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058910
[TBL] [Abstract][Full Text] [Related]
10. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
[TBL] [Abstract][Full Text] [Related]
11. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
Adnan A; Basu S
J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
[TBL] [Abstract][Full Text] [Related]
12.
Delpassand ES; Ranganathan D; Wagh N; Shafie A; Gaber A; Abbasi A; Kjaer A; Tworowska I; Núñez R
J Nucl Med; 2020 Jun; 61(6):890-896. PubMed ID: 31924723
[TBL] [Abstract][Full Text] [Related]
13. [
Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
[TBL] [Abstract][Full Text] [Related]
14. An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose
Loft M; Ladefoged CN; Johnbeck CB; Carlsen EA; Oturai P; Langer SW; Knigge U; Andersen FL; Kjaer A
J Nucl Med; 2023 Jun; 64(6):951-959. PubMed ID: 37169532
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for
Virgolini I; Bahri S; Kjaer A; Grønbæk H; Iversen P; Carlsen EA; Loft M; Knigge U; Maffey-Steffan J; Powell C; Miller CG; Rohban T; McEwan S; Czernin J
J Nucl Med; 2022 Mar; 63(3):376-383. PubMed ID: 34215673
[No Abstract] [Full Text] [Related]
16. A prospective head-to-head comparison of
Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
[TBL] [Abstract][Full Text] [Related]
17. The value of
Liu KY; Goldrich DY; Ninan SJ; Filimonov A; Lam H; Govindaraj S; Iloreta AM
Head Neck; 2021 Jun; 43(6):E30-E40. PubMed ID: 33786927
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Utility of Total
Tirosh A; Papadakis GZ; Millo C; Hammoud D; Sadowski SM; Herscovitch P; Pacak K; Marx SJ; Yang L; Nockel P; Shell J; Green P; Keutgen XM; Patel D; Nilubol N; Kebebew E
Gastroenterology; 2018 Mar; 154(4):998-1008.e1. PubMed ID: 29155309
[TBL] [Abstract][Full Text] [Related]
20. Standardized image quality for
Cox CPW; Segbers M; Graven LH; Brabander T; van Assema DME
EJNMMI Res; 2020 Mar; 10(1):27. PubMed ID: 32201912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
